Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs Journal Article


Authors: Lussier, Y. A.; Khodarev, N. N.; Regan, K.; Corbin, K.; Li, H.; Ganai, S.; Khan, S. A.; Gnerlich, J.; Darga, T. E.; Fan, H.; Karpenko, O.; Paty, P. B.; Posner, M. C.; Chmura, S. J.; Hellman, S.; Ferguson, M. K.; Weichselbaum, R. R.
Article Title: Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs
Abstract: Rationale: Strategies to stage and treat cancer rely on a presumption of either localized or widespread metastatic disease. An intermediate state of metastasis termed oligometastasis(es) characterized by limited progression has been proposed. Oligometastases are amenable to treatment by surgical resection or radiotherapy. Methods: We analyzed microRNA expression patterns from lung metastasis samples of patients with ≤5 initial metastases resected with curative intent. Results: Patients were stratified into subgroups based on their rate of metastatic progression. We prioritized microRNAs between patients with the highest and lowest rates of recurrence. We designated these as high rate of progression (HRP) and low rate of progression (LRP); the latter group included patients with no recurrences. The prioritized microRNAs distinguished HRP from LRP and were associated with rate of metastatic progression and survival in an independent validation dataset. Conclusion: Oligo- and poly- metastasis are distinct entities at the clinical and molecular level. © 2012 Lussier et al.
Journal Title: PLoS ONE
Volume: 7
Issue: 12
ISSN: 1932-6203
Publisher: Public Library of Science  
Date Published: 2012-01-01
Start Page: e50141
Language: English
DOI: 10.1371/journal.pone.0050141
PROVIDER: scopus
PMCID: PMC3518475
PUBMED: 23251360
DOI/URL:
Notes: --- - "Export Date: 2 January 2013" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Philip B Paty
    496 Paty